Batch Effects And Identifiability In QTL Mapping

Why Batch and Identifiability Matter

Molecular measurements can differ systematically across assay plates, processing dates, reagent lots, sequencing runs, or laboratories. Such a batch effect is a technical shift in the measured phenotype associated with how or when samples were processed. If genotype groups are distributed differently across batches, a measured genotype–expression association can combine a biological QTL effect with a technical difference. Including batch in a regression model can separate these contributions only when the observed design contains enough genotype variation independent of batch.

This is an identifiability question, not merely a question of which software option to select. If each genotype occurs in multiple batches, the model may distinguish batch shifts from the genotype slope. If genotype and batch are perfectly aligned, the data contain no comparison that can tell those effects apart. No adjustment method can create that missing comparison.

A QTL Model With Batch Effects

For one molecular phenotype measured in \(n\) donors, let \(y_i\) be the phenotype for donor \(i\), and let \(g_i\) be that donor's genotype dosage at the variant, conventionally coded as 0, 1, or 2 copies of the effect allele. Let \(b_i\) denote the technical batch. A fixed-effects model with \(K\) batches can be written using an intercept and \(K-1\) batch indicators:

Here, \(\beta\) is the expected difference in the phenotype per additional effect-allele copy, holding batch fixed. Each \(\gamma_k\) is the mean shift for batch \(k\) relative to the reference batch, holding genotype fixed. For the ordinary least-squares interpretation and standard errors used below, assume the conditional mean follows this additive model, the errors have mean zero given genotype and batch, and the errors are independent with a common variance. These assumptions concern the model and inference; they do not guarantee that the design can identify \(\beta\).

This condition is also described using matrix rank. Let \(Z\) contain the intercept and batch indicators, and let \(g\) be the vector of genotype dosages. The coefficient \(\beta\) is identifiable in the model with batch if adding \(g\) to \(Z\) increases the rank of the design matrix. In practical terms, there must be genotype contrasts within at least some batches. Genotypes need not be equally frequent in every batch, but genotype cannot be a deterministic function of batch.

Residualizing Genotype: A Short Justification

The role of within-batch genotype variation can be made precise. Let \(P_Z\) project a vector onto the columns of \(Z\), and let \(M_Z=I-P_Z\) remove its fitted intercept and batch means. Thus \(\tilde{g}=M_Zg\) is the genotype vector after subtracting its batch-specific mean (and the corresponding intercept representation). The same operation on the phenotype gives \(\tilde{y}=M_Zy\).

The least-squares estimate of the genotype coefficient is the slope obtained from these residualized vectors:

To see why, first choose any fixed value of \(\beta\). The best-fitting batch and intercept coefficients minimize the squared residuals after removing the part explained by \(Z\). The remaining squared error is \((y-\beta g)^{\mathsf T}M_Z(y-\beta g)\). Expanding this quadratic in \(\beta\), differentiating, and setting the derivative to zero gives

This division is valid exactly when \(g^{\mathsf T}M_Zg>0\). If that quantity is zero, the genotype vector lies entirely in the span of the intercept and batch indicators; there is no residualized genotype contrast. Under the stated common-variance model, when the coefficient is identifiable, its standard error is estimated by

As genotype–batch imbalance increases, the remaining genotype variation can become small. The model may still identify \(\beta\), but the standard error can grow because the denominator \(g^{\mathsf T}M_Zg\) is small.

Partial Confounding: Adjustment Is Possible, but Less Precise

With partial rather than perfect confounding, some batches contain more of one genotype than another, but the genotype distributions are not identical across batches. If at least one batch has within-batch genotype variation, the genotype coefficient can generally be estimated under the additive model. It is estimated from those within-batch contrasts, not from the between-batch differences that the batch indicators absorb.

Why an Unadjusted Association Can Be Misleading

When genotype frequencies differ across batches and batches have different phenotype levels, an unadjusted comparison can combine the within-batch genotype contrast with the between-batch technical shift. Adjustment changes the comparison: the coefficient is estimated using genotype differences after subtracting batch means. The following example shows how the two estimates can differ.

Diagnosing the Design Before Fitting the Model

A useful first step is to tabulate genotype by batch before interpreting any adjusted result. For a biallelic variant, inspect counts for dosages 0, 1, and 2 in each batch, and look for empty cells or batches with only one observed dosage. A cross-tabulation reveals structural overlap, while a plot of phenotype by genotype, marked by batch, can reveal batch-specific shifts or possible slope differences.

A positive rank check is not a guarantee of useful precision: a tiny amount of within-batch variation can technically identify a coefficient while leaving it poorly estimated. Conversely, a batch containing only one genotype does not by itself make the entire model unidentified if other batches provide genotype contrasts; it does mean that this batch contributes no within-batch information about the slope.

Adjustment Is Not the Same as Erasing Batch

Including batch as a covariate estimates the genotype association conditional on the batch labels in the model. This is conceptually different from subtracting a batch mean from every phenotype before QTL analysis. A preliminary correction can remove real genotype signal if genotype is associated with batch: the batch mean may itself reflect different genotype composition. If the batch and genotype effects cannot be separated, a correction procedure cannot know which part to preserve.

The most reliable remedy for perfect confounding is at the design stage: distribute genotype groups across processing batches, randomize sample placement where feasible, and retain accurate batch records. When the samples have already been processed and genotype is perfectly confounded with batch, report that the genotype effect is not identified from those data rather than presenting a batch-adjusted estimate as if the design supported it.

Common Mistakes

• Assuming that adding batch always solves confounding. Adding a covariate only separates effects when the design contains independent variation. Identical genotype and batch indicator columns make the genotype coefficient unidentifiable.
• Calling partial confounding impossible to adjust. Unequal genotype frequencies across batches do not automatically prevent estimation. If there is sufficient within-batch genotype variation, a conditional slope can be estimated, although its standard error may be larger.
• Interpreting the crude genotype difference as the adjusted QTL coefficient. When genotype composition and phenotype levels differ across batches, the crude difference mixes within-batch and between-batch comparisons.
• Treating a reported software coefficient as proof of identification. A program can impose a constraint or omit a redundant column when the design is rank deficient. Such output depends on a convention, not information separating genotype from batch.
• Assuming adjustment makes the result causal. The coefficient is a conditional association under the stated model. Batch adjustment alone does not establish causation or address every source of bias.